BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 1818314)

  • 21. [The lack of the CpNpG methylation at the 5'-terminal region of the human calcitonin gene in norm and in leukemia [].
    Bur'ianov IaI; Shevchuk TV; Zakharchenko NS; D'iachenko OV; Marinich DV; Vorob'ev IA
    Bioorg Khim; 2000 May; 26(5):397-9. PubMed ID: 10900512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcitonin gene methylation in chronic myeloproliferative disorders.
    Ihalainen J; Juvonen E; Savolainen ER; Ruutu T; Palotie A
    Leukemia; 1994 Feb; 8(2):230-5. PubMed ID: 8309247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cytogenetic and molecular studies in patients with chronic myelogenous leukemia without Ph chromosome and with unusual Ph translocation].
    Xue YQ
    Zhonghua Yi Xue Za Zhi; 1993 Apr; 73(4):209-12, 252-3. PubMed ID: 8395313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methylation status of RASSF1A in patients with chronic myeloid leukemia.
    Avramouli A; Tsochas S; Mandala E; Katodritou E; Ioannou M; Ritis K; Speletas M
    Leuk Res; 2009 Aug; 33(8):1130-2. PubMed ID: 19193434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal methylation of the calcitonin gene in human colonic neoplasms.
    Silverman AL; Park JG; Hamilton SR; Gazdar AF; Luk GD; Baylin SB
    Cancer Res; 1989 Jul; 49(13):3468-73. PubMed ID: 2731168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stage- and lineage-specific expression of the HOXA10 homeobox gene in normal and leukemic hematopoietic cells.
    Lawrence HJ; Sauvageau G; Ahmadi N; Lopez AR; LeBeau MM; Link M; Humphries K; Largman C
    Exp Hematol; 1995 Oct; 23(11):1160-6. PubMed ID: 7556525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increasing methylation of the calcitonin gene during disease progression in sequential samples from CML patients.
    Mills KI; Guinn BA; Walsh VA; Burnett AK
    Leuk Res; 1996 Sep; 20(9):771-5. PubMed ID: 8947587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methylation of histones in myeloid leukemias as a potential marker of granulocyte abnormalities.
    Lukásová E; Koristek Z; Falk M; Kozubek S; Grigoryev S; Kozubek M; Ondrej V; Kroupová I
    J Leukoc Biol; 2005 Jan; 77(1):100-11. PubMed ID: 15507473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
    Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
    Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
    Engelhardt M; Mackenzie K; Drullinsky P; Silver RT; Moore MA
    Cancer Res; 2000 Feb; 60(3):610-7. PubMed ID: 10676644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integration of amplified BCR/ABL fusion genes into the short arm of chromosome 17 as a novel mechanism of disease progression in chronic myeloid leukemia.
    Metzke-Heidemann S; Harder L; Gesk S; Schoch R; Jenisch S; Grote W; Siebert R; Schlegelberger B
    Genes Chromosomes Cancer; 2001 May; 31(1):10-4. PubMed ID: 11284030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene silencing of the tyrosine phosphatase SHP1 gene by aberrant methylation in leukemias/lymphomas.
    Oka T; Ouchida M; Koyama M; Ogama Y; Takada S; Nakatani Y; Tanaka T; Yoshino T; Hayashi K; Ohara N; Kondo E; Takahashi K; Tsuchiyama J; Tanimoto M; Shimizu K; Akagi T
    Cancer Res; 2002 Nov; 62(22):6390-4. PubMed ID: 12438221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Study on hypermethylation of the calcitonin gene in malignant hematological disorders].
    Tang Y; Deng C; Du Q; Li G
    Hua Xi Yi Ke Da Xue Xue Bao; 2001 Mar; 32(1):86-8. PubMed ID: 12733364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of the polymerase chain reaction to detect hypermethylation in the calcitonin gene. A new, sensitive approach to monitor tumor cells in acute myelogenous leukemia.
    Fukuhara T; Hooper WC; Baylin SB; Benson J; Pruckler J; Olson AC; Evatt BL; Vogler WR
    Leuk Res; 1992 Oct; 16(10):1031-40. PubMed ID: 1405705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypermethylation of 5'-region of the human calcitonin gene in leukemias: structural features and diagnostic significance.
    Marinitch DV; Vorobyev IA; Holmes JA; Zakharchenko NS; Dyachenko OV; Buryanov YI; Shevchuk TV
    Biochemistry (Mosc); 2004 Mar; 69(3):340-9. PubMed ID: 15061703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypermethylation of the 5' region of the calcitonin gene is a property of human lymphoid and acute myeloid malignancies.
    Baylin SB; Fearon ER; Vogelstein B; de Bustros A; Sharkis SJ; Burke PJ; Staal SP; Nelkin BD
    Blood; 1987 Aug; 70(2):412-7. PubMed ID: 3607279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypermethylation of calcitonin gene in adult acute leukemia at diagnosis and during complete remission.
    Thomas X; Teillon MH; Belhabri A; Rimokh R; Fiere D; Magaud JP; Archimbaud E
    Hematol Cell Ther; 1999 Feb; 41(1):19-26. PubMed ID: 10193642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methylation pattern of calcitonin (CALCA) gene in pediatric acute leukemia.
    Ismail EA; El-Mogy MI; Mohamed DS; El-Farrash RA
    J Pediatr Hematol Oncol; 2011 Oct; 33(7):534-42. PubMed ID: 21423046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Gene diagnosis of early-stage cancers].
    Takaku F
    Nihon Rinsho; 1989 May; 47(5):1095-101. PubMed ID: 2664270
    [No Abstract]   [Full Text] [Related]  

  • 40. Development of molecular genetic methods for monitoring myeloid malignancies.
    Palotie A; Syvänen AC
    Scand J Clin Lab Invest Suppl; 1993; 213():29-38. PubMed ID: 8322016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.